Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients [Phase 3]
A Phase 3 pediatric trial evaluated romiplostim for safety and efficacy in immune thrombocytopenia, with results posted in January 2017.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Regulatory B Cells and Chronic Immune Thrombocytopenia
Clinical trial update indicating the study on Regulatory B Cells in chronic immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating Rituximab, Eltrombopag, and Dexamethasone as frontline therapy for immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia [Phase 3]
An open-label Phase 3 study of IV-Globulin SN Inj.10% for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
This completed clinical trial from Beth Israel Medical Center evaluated whether extended platelet parameters can distinguish immune thromboc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Treatment of ITP With Rituximab and / or Accutane [Phase 2]
A Phase 2 clinical trial evaluating rituximab, with or without isotretinoin (Accutane), for immune thrombocytopenia, sponsored by Peking Uni…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. [Phase 3]
This Phase 3 randomized trial in children with immune thrombocytopenia compared intravenous immunoglobulin (IVIG) alone to IVIG with high-do…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Thrombocytopenia in Gestational Period [Phase 2, Phase 3]
This clinical trial update notes Phase 2 and Phase 3 studies related to thrombocytopenia during pregnancy in the context of immune thrombocy…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: An Investigation of rhTPO With Different Frequencies in the Management of ITP [Phase 3]
Phase 3 trial evaluating different dosing frequencies of recombinant human thrombopoietin (rhTPO) for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 clinical trial evaluating dexamethasone at different doses for managing immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) [Phase 3]
This update reports the completion of a Phase 3 trial evaluating recombinant human thrombopoietin in combination with rituximab for immune t…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Caffeic Acid Tablets as a Second-line Therapy for ITP [Phase 3]
This update notes the completion of a Phase 3 trial evaluating caffeic acid tablets as a second-line therapy for immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP [Phase 3]
A Phase 3 trial comparing rhTPO plus dexamethasone versus high-dose dexamethasone for initial treatment of immune thrombocytopenia has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP [Phase 3]
A Phase 3 trial comparing rhTPO plus Rituximab versus low-dose Rituximab alone in immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial comparing high-dose dexamethasone to conventional-dose prednisone for initial treatment of primary immune thrombocytopenia has…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Autoantibody Specificity and Response to IVIG in ITP
A completed Shandong University–sponsored trial evaluating autoantibody specificity in immune thrombocytopenia and the response to intraveno…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura [Phase 3]
A Phase 3 clinical trial in immune thrombocytopenia completed, with results posted in February 2016; sponsor was Instituto Grifols.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP [Phase 2]
Phase 2 clinical trial from Ain Shams University assesses safety, tolerability, and efficacy of a single-dose low-cost minipool intravenous …
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training
Completed clinical trial evaluating the proportion of patients with immune thrombocytopenia who correctly self-administer romiplostim after …
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 1]
Phase 1 trial evaluating the safety and efficacy of Hetrombopag Olamine in patients with immune thrombocytopenia (ITP), sponsored by Jiangsu…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Traditional Chinese Medicine for childhood chronic immune thrombocytopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults [NA]
This clinical trial update reports on a completed study investigating natural killer cells in adults with immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Phase 4]
A Phase 4 longitudinal study evaluating eltrombopag over two years in adults with chronic immune thrombocytopenia who had prior treatment; t…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura. [Phase 2]
Phase 2 study evaluating rituximab (MabThera) in patients with immune thrombocytopenia has completed enrollment, with results posted in Febr…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP [Phase 2]
A Phase 2 observational study evaluating the efficacy of biweekly romiplostim in adult patients with immune thrombocytopenia.